• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Home time among older adults with acute myeloid leukemia by therapy intensity.

作者信息

Jensen Christopher E, Deal Allison M, Wardell Alexis C, Heiling Hillary M, Beke Konan E, Richardson Daniel R

机构信息

University of North Carolina School of Medicine, Chapel Hill, NC, USA; University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

出版信息

Haematologica. 2024 May 1;109(5):1588-1592. doi: 10.3324/haematol.2023.284133.

DOI:10.3324/haematol.2023.284133
PMID:38124658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11063832/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b9/11063832/9a2ba70fe039/1091588.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b9/11063832/9a2ba70fe039/1091588.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b9/11063832/9a2ba70fe039/1091588.fig1.jpg

相似文献

1
Home time among older adults with acute myeloid leukemia by therapy intensity.老年急性髓系白血病患者按治疗强度划分的回家时间
Haematologica. 2024 May 1;109(5):1588-1592. doi: 10.3324/haematol.2023.284133.
2
When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era.少即是多：重新评估强化化疗在现代老年急性髓系白血病患者中的作用
J Clin Oncol. 2021 Oct 1;39(28):3104-3108. doi: 10.1200/JCO.21.00960. Epub 2021 Aug 18.
3
Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.复发或难治性急性髓系白血病成人患者早期死亡的预测
Leuk Lymphoma. 2016 Oct;57(10):2421-4. doi: 10.3109/10428194.2015.1135436. Epub 2016 Jan 11.
4
[Complications associated with short-term intensive consolidation chemotherapy for adults with acute myelogenous leukemia].[成人急性髓性白血病短期强化巩固化疗相关并发症]
Gan To Kagaku Ryoho. 1993 Sep;20(12):1869-72.
5
Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.在异基因干细胞移植前，使用吉妥珠单抗奥唑米星和阿糖胞苷进行细胞减灭术治疗复发/难治性急性髓系白血病。
Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6.
6
Lomustine in older patients with acute myeloid leukaemia.洛莫司汀用于老年急性髓系白血病患者。
Lancet Oncol. 2018 Nov;19(11):e584. doi: 10.1016/S1470-2045(18)30740-X. Epub 2018 Oct 4.
7
Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.MIDAM方案治疗复发或难治性急性髓系白血病患者缓解后策略的结局与影响
Am J Hematol. 2019 Jan;94(1):E32-E35. doi: 10.1002/ajh.25332. Epub 2018 Nov 25.
8
Relapse and death during first remission in acute myeloid leukemia.急性髓系白血病首次缓解期的复发与死亡
Haematologica. 2008 Apr;93(4):633-4. doi: 10.3324/haematol.12366.
9
Intensive induction in older patients with acute myeloid leukemia: an initial struggle with later rewards?老年急性髓系白血病患者的强化诱导治疗：初期艰难但后期有回报？
Haematologica. 2024 May 1;109(5):1331-1333. doi: 10.3324/haematol.2023.284780.
10
Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.成人急性非淋巴细胞白血病：TAD缓解诱导疗法的治疗结果
Haematol Blood Transfus. 1990;33:309-13. doi: 10.1007/978-3-642-74643-7_56.

引用本文的文献

1
Comprehensive pan-cancer analysis of NLRs family as prognostic and immunity markers based on multi-omics data.基于多组学数据对NLRs家族作为预后和免疫标志物进行全面的泛癌分析。
Discov Oncol. 2025 Jul 1;16(1):1250. doi: 10.1007/s12672-025-02982-6.
2
Time's up: the urgency to investigate time toxicity in patients with genitourinary malignancies.时间到了：研究泌尿生殖系统恶性肿瘤患者时间毒性的紧迫性。
Ther Adv Med Oncol. 2024 Dec 11;16:17588359241305088. doi: 10.1177/17588359241305088. eCollection 2024.
3
Intensive induction in older patients with acute myeloid leukemia: an initial struggle with later rewards?

本文引用的文献

1
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.与 CCTG LY.12 试验中的癌症治疗相关的接触天数。
Oncologist. 2023 Sep 7;28(9):799-803. doi: 10.1093/oncolo/oyad128.
2
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.成人急性髓系白血病当前治疗方法的更新：强化治疗还是非强化治疗？这是个问题。
Haematologica. 2023 Feb 1;108(2):342-352. doi: 10.3324/haematol.2022.280802.
3
Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens.
老年急性髓系白血病患者的强化诱导治疗：初期艰难但后期有回报？
Haematologica. 2024 May 1;109(5):1331-1333. doi: 10.3324/haematol.2023.284780.
老年急性髓系白血病患者接受阿扎胞苷或 venetoclax 为基础方案治疗时的居家时间。
Haematologica. 2023 Apr 1;108(4):1006-1014. doi: 10.3324/haematol.2022.280728.
4
Health care-related time costs in patients with metastatic breast cancer.转移性乳腺癌患者的医疗相关时间成本。
Cancer Med. 2020 Nov;9(22):8423-8431. doi: 10.1002/cam4.3461. Epub 2020 Sep 21.
5
Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.转移性胰腺导管腺癌接受姑息性化疗的机会成本。
JCO Oncol Pract. 2020 Aug;16(8):e678-e687. doi: 10.1200/JOP.19.00328. Epub 2020 Mar 4.
6
Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies.生命终末期 6 个月内居家天数：血液病患者终末期照护质量指标
Leuk Lymphoma. 2020 Jan;61(1):146-155. doi: 10.1080/10428194.2019.1654095. Epub 2019 Aug 22.
7
Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States.评估美国急性髓细胞白血病相关治疗健康状况的效用值。
Health Qual Life Outcomes. 2018 Sep 21;16(1):193. doi: 10.1186/s12955-018-1013-9.
8
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.